Raymond James & Associates’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$782K	Buy	8,701 +58	+0.7%	+$5.06K	﹤0.01%	2842
2024 Q2	$696K	Sell	8,643 -186	-2%	-$13.8K	﹤0.01%	2860
2024 Q1	$705K	Buy	8,829 +3,412	+63%	+$286K	﹤0.01%	2839
2023 Q4	$431K	Sell	5,417 -51	-0.9%	-$3.41K	﹤0.01%	3043
2023 Q3	$382K	Sell	5,468 -2,603	-32%	-$195K	﹤0.01%	3047
2023 Q2	$580K	Buy	8,071 +3,100	+62%	+$229K	﹤0.01%	2841
2023 Q1	$307K	Sell	4,971 -1,923	-28%	-$126K	﹤0.01%	3230
2022 Q4	$532K	Buy	6,894 +973	+16%	+$58.2K	﹤0.01%	2860
2022 Q3	$264K	Buy	5,921 +15	+0.3%	+$750	﹤0.01%	3260
2022 Q2	$226K	Buy	5,906 +277	+5%	+$8.76K	﹤0.01%	3420
2022 Q1	$233K	Buy	5,629 +195	+4%	+$6.04K	﹤0.01%	3578
2021 Q4	$205K	Buy	+5,434	New	+$200K	﹤0.01%	3686
2021 Q3	–	Sell	-7,134	Closed	-$481K	–	4118
2021 Q2	$481K	Buy	7,134 +3,298	+86%	+$198K	﹤0.01%	3098
2021 Q1	$217K	Hold	3,836	–	–	﹤0.01%	3557
2020 Q4	$313K	Sell	3,836 -167	-4%	-$12.5K	﹤0.01%	3100
2020 Q3	$285K	Hold	4,003	–	–	﹤0.01%	2986
2020 Q2	$329K	Sell	4,003 -264	-6%	-$20.3K	﹤0.01%	2864
2020 Q1	$251K	Sell	4,267 -3,408	-44%	-$278K	﹤0.01%	2883
2019 Q4	$793K	Sell	7,675 -15,696	-67%	-$634K	﹤0.01%	2421
2019 Q3	$473K	Sell	23,371 -2,000	-8%	-$51.4K	﹤0.01%	2689
2019 Q2	$653K	Buy	+25,371	New	+$509K	﹤0.01%	2485